DE69113773D1 - Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma. - Google Patents
Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.Info
- Publication number
- DE69113773D1 DE69113773D1 DE69113773T DE69113773T DE69113773D1 DE 69113773 D1 DE69113773 D1 DE 69113773D1 DE 69113773 T DE69113773 T DE 69113773T DE 69113773 T DE69113773 T DE 69113773T DE 69113773 D1 DE69113773 D1 DE 69113773D1
- Authority
- DE
- Germany
- Prior art keywords
- triazoles
- alkylthio
- aryl
- treatment
- over
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63066690A | 1990-12-20 | 1990-12-20 | |
| US07/769,201 US5158968A (en) | 1987-01-27 | 1991-10-04 | 3-aryl-5-alkylthio-4H-1,2,4-traizoles for treatment of hyperreflexia due to spinal trauma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69113773D1 true DE69113773D1 (de) | 1995-11-16 |
| DE69113773T2 DE69113773T2 (de) | 1996-04-25 |
Family
ID=27091200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69113773T Expired - Fee Related DE69113773T2 (de) | 1990-12-20 | 1991-12-19 | Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0495226B1 (de) |
| JP (1) | JP3048191B2 (de) |
| KR (1) | KR100192647B1 (de) |
| AT (1) | ATE128867T1 (de) |
| AU (1) | AU644500B2 (de) |
| DE (1) | DE69113773T2 (de) |
| DK (1) | DK0495226T3 (de) |
| IE (1) | IE68424B1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994027513A1 (en) * | 1993-05-28 | 1994-12-08 | Origin Medsystems, Inc. | Retracting tip trocar with plunger sensor |
| DE4339412A1 (de) * | 1993-11-18 | 1995-05-24 | Bayer Ag | Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen |
| JPH09315972A (ja) * | 1996-03-22 | 1997-12-09 | Chugai Pharmaceut Co Ltd | 脊髄損傷治療剤 |
| AR022229A1 (es) * | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2593084B2 (ja) * | 1986-12-19 | 1997-03-19 | メレルダウファーマスーティカルズ インコーポレーテッド | ５−アリールー３ｈ−１，２，４−トリアゾールー３−オン類の神経変性障害の処置への用途 |
| US4900743A (en) * | 1987-01-27 | 1990-02-13 | Merrell Dow Pharmaceuticals Inc. | 3-aryl-5-alkylthio-4H-1,2,4-triazoles |
-
1991
- 1991-12-16 AU AU89692/91A patent/AU644500B2/en not_active Ceased
- 1991-12-19 DE DE69113773T patent/DE69113773T2/de not_active Expired - Fee Related
- 1991-12-19 AT AT91121811T patent/ATE128867T1/de not_active IP Right Cessation
- 1991-12-19 DK DK91121811.3T patent/DK0495226T3/da active
- 1991-12-19 EP EP91121811A patent/EP0495226B1/de not_active Expired - Lifetime
- 1991-12-19 KR KR1019910023429A patent/KR100192647B1/ko not_active IP Right Cessation
- 1991-12-19 IE IE446091A patent/IE68424B1/en not_active IP Right Cessation
- 1991-12-20 JP JP3355001A patent/JP3048191B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE128867T1 (de) | 1995-10-15 |
| EP0495226A2 (de) | 1992-07-22 |
| EP0495226B1 (de) | 1995-10-11 |
| DE69113773T2 (de) | 1996-04-25 |
| IE68424B1 (en) | 1996-06-12 |
| JP3048191B2 (ja) | 2000-06-05 |
| EP0495226A3 (en) | 1992-09-16 |
| AU8969291A (en) | 1992-06-25 |
| KR920011490A (ko) | 1992-07-24 |
| AU644500B2 (en) | 1993-12-09 |
| DK0495226T3 (da) | 1995-11-27 |
| KR100192647B1 (ko) | 1999-06-15 |
| IE914460A1 (en) | 1992-07-01 |
| JPH04334373A (ja) | 1992-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2052871T3 (es) | Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano. | |
| DE69212620D1 (de) | Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie | |
| ATE234615T1 (de) | Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren | |
| DK465488D0 (da) | Farmaceutisk praeparat indeholdende en triazol-forbindelse | |
| DE69635305D1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
| ATE79031T1 (de) | Verwendung von ketonderivaten zur behandlung von depressionen. | |
| DE69405919T2 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| DE69113773D1 (de) | Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma. | |
| AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
| ATE123942T1 (de) | 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva. | |
| DE69231883D1 (de) | 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten | |
| ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
| DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
| DK0510913T3 (da) | Farmaceutiske sammensætninger indeholdende calcitonin | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| DE68926222D1 (de) | Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen | |
| DE68918449T2 (de) | Siliziumverbindungen zur behandlung von knochen. | |
| DE69117566T2 (de) | Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen | |
| DE69218544D1 (de) | Verwendung von BMY 14802 zur Behandlung von Angstzuständen bei Patienten mit Benzodiazepin-Entzugserscheinungen | |
| ATE30032T1 (de) | N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer. | |
| DE68914886D1 (de) | Mittel zur Behandlung von Raynaud's Krankheit. | |
| DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
| ATE91886T1 (de) | Praeparat zur behandlung von erektionsstoerungen. | |
| ZA919909B (en) | 3-aryl-5-alkylthio-4H-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma. | |
| ATE96150T1 (de) | Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |